4
Changes in Ownership
C4 Therapeutics, Inc. Filed Acc 0001662579-24-000014
Chief Financial Officer gave up 1,301 shares (to pay taxes)
- Chief Financial Officer acquired 36,700 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Adams Kendra · Chief Financial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-02-13 | Shares withheld for taxes : show line 1 in the form | −1,301 | $6.53 | $8,496 | 45,339 | D |
| 2024-02-14 | Grant or award : show line 2 in the form | +36,700 | 82,039 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-02-14 | Grant or award : show line 3 in the form Stock Option (Right to Buy) | +165,300 | 165,300 | D |
Loading xslF345X05/wk-form4_1708034519.xml…